Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial
Related Posts
Moucheraud C, Chibaka S, Golub G, Kalande P, Makwaya A, Ochieng E, Ogutu V, Phiri K, Phiri S, Hoffman RM. Factors associated with cervical cancer[...]
Jia Q, Bowen RA, Masleša-Galić S, Horwitz MA. rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal[...]
Kibeti DM, Hoff NA, Merritt S, Lulebo AM, Kasonga JN, Mvuama NM, Luhata CL, Nkamba DM, Otomba JS, El Mourid A, Cikomola AMW, Mukendi JC,[...]